Advertisement

Monoclonal Antibody Against Human Fibrin for Imaging Thrombi

  • John G. McAfee
  • Zachary D. Grossman
  • Scott F. Rosebrough
  • Gopal Subramanian
  • Catherine Ritter-Hrncirik
  • Larry S. Witanowski
Part of the NATO ASI Series book series (NSSA, volume 152)

Abstract

The detection and localization of venous thrombi, most common in the lower extremities and pelvis, remain a major diagnostic problem in clinical medicine. Although radiographic venography with contrast medium is highly sensitive and specific, the injections are frequently painful, and reactions from large doses of intravenous contrast media of varying severity occur. In the search for a less invasive diagnostic procedure, gamma camera imaging has been tried frequently, using a number of radioactive agents, including fibrinogen (1), split fibrin products (2,3), streptokinase, urokinase, plasminogen, plasmin (4), tissue plasminogen activator, and labeled platelets (5). Labeled fibrinogen fragment E was successful in pigs (4), but apparently less successful in human trials. Labeled platelets have consistently localized thrombi less than 12 hours old and even up to one day old, but older thrombi encountered in clinical practice are localized poorly (3). In general, the results of radionuclide imaging for thrombus detection have been disappointing. To attempt to improve the efficacy of camera imaging, we have explored the use of a labeled monoclonal antibody against human fibrin in a canine model.

Keywords

Venous Thrombus Radiation Dose Estimate Fresh Thrombus Indium Chloride Gianturco Coil 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    V. V. Kakkar, Fibrinogen uptake test for detection of deep vein thrombosis: Review of current practice, Semin. Nucl. Med. 7:229–224 (1977).PubMedCrossRefGoogle Scholar
  2. 2.
    S. A. Olexa, L. C. Knight, and A. Z. Budzynski, Use of Radio-labeled Peptide Derived from Crosslinked Fibrin to Locate Thrombi In Vivo, United States Patent #4,427,646, Jan. 1984.Google Scholar
  3. 3.
    L. C. Knight, S. A. Olexa, L. S. Malmud et al., Specific uptake of radioiodinated Fragment E1 by venous thrombi in pigs, J. Clin. Invest. 72:2007–2013 (1983).PubMedCrossRefGoogle Scholar
  4. 4.
    C. G. Olsson, V. Albrechtsson, L. Darte et al., Technetium-99m plasmin for rapid detection of deep vein thrombosis, Nucl. Med. Communications:41–52 (1982).Google Scholar
  5. 5.
    Z. D. Grossman, B. W. Wistow, J. G. McAfee et al., Technet ium-99m-Oxine and Indium-111-Oxine Labeled Platelets: Part II: Localization of Experimentally-Induced Vascular Lesions, J. Nucl. Med. 19:488–491 (1978).PubMedGoogle Scholar
  6. 6.
    B. Kudryk, A. Rohoza, M. Ahabi et al., Specificity of a monoclonal antibody for the NH2-terminal region of fibrin, Mole. Immun. 21:89–94 (1984).CrossRefGoogle Scholar
  7. 7.
    K. Y. Hui, E. Haber, G. R. Matsueda, Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen, Science 222:1129–1131 (1983).PubMedCrossRefGoogle Scholar
  8. 8.
    T. Matsumoto, Y. Nishijima, Y. Teramura et al., Monoclonal antibodies to fibrinogen — Fibrin degradation products which contain D-domain, Thrombosis Res. 38:297–302 (1985).CrossRefGoogle Scholar
  9. 9.
    V. J. Marder, C. W. Francis, and R. F. Doolittle, Fibrinogen structure and physiology, in: “Hemostasis and Thrombosis: Basic Principles and Clinical Practice,” J. B. Lippincott Co., Philadelphia (1982), pp. 145–163.Google Scholar
  10. 10.
    S. F. Rosebrough, Z. D. Grossman, and J. G. McAfee, Purification of fibrin-specific monoclonal antibody from ascites fluid by preparative isoelectric focusing, Immunol. Letters 12:147–151 (1986).CrossRefGoogle Scholar
  11. 11.
    D. J. Hnatowitch, W. W. Layne, R. L. Childs et al., Radioactive labeling of antibody: A simple and efficient method, Science 220:613–615 (1983).CrossRefGoogle Scholar
  12. 12.
    V. P. Chuang, S. Wallace, and C. Gianturco, A new improved coil for tapered tip catheter for arterial occlusion, Radiology 135:507–509 (1980).PubMedGoogle Scholar
  13. 13.
    S. F. Rosebrough, B. Kudryk, Z. D. Grossman et al., Radio-immunoimaging of venous thrombi using Iodine-131 monoclonal antibody, Radiology 156:515–517 (1985).PubMedGoogle Scholar
  14. 14.
    J. D. Rodwell, V. L. Alvarez, C. Lee et al., Site-specific covalent modification of monoclonal antibodies: In vitro and in vivo evaluations, Proc. Nat. Acad. Sci. 83:2632–2636 (1986).PubMedCrossRefGoogle Scholar
  15. 15.
    J. C. Saccavini, J. Bohy, and J. Bruneau, Radiolabeling of monoclonal antibodies, Nucl. Med. Biol. 13:191–194 (1986).Google Scholar
  16. 16.
    D. C. Rijken, M. Hoylaerts, and D. Collen, Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator, J. Biol. Chem. 257:2920–2925 (1982).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • John G. McAfee
    • 1
  • Zachary D. Grossman
    • 1
  • Scott F. Rosebrough
    • 1
  • Gopal Subramanian
    • 1
  • Catherine Ritter-Hrncirik
    • 1
  • Larry S. Witanowski
    • 1
  1. 1.Divisions of Nuclear Medicine and Radiological Sciences Department of RadiologyS.U.N.Y. Health Science CenterSyracuseUSA

Personalised recommendations